ArticleOncoimmunology2022

Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma.

Sofie Kirial Mørk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.